Unveiling the macrophage dynamics in osteoarthritic joints: From inflammation to therapeutic strategies

Archive ouverte

Gaigeard, Nicolas | Cardon, Anaïs | Le Goff, Benoit | Guicheux, Jérôme | Boutet, Marie-Astrid

Edité par CCSD ; Elsevier -

International audience. Osteoarthritis (OA) is an incurable, painful, and debilitating joint disease affecting over 500 million people worldwide. The OA joint tissues are infiltrated by various immune cells, particularly macrophages, which are able to induce or perpetuate inflammation. Notably, synovitis and its macrophage component represent a target of interest for developing treatments. In this review, we describe the latest advances in understanding the heterogeneity of macrophage origins, phenotypes, and functions in the OA joint and the effect of current symptomatic therapies on these cells. We then highlight the therapeutic potential of anticytokines/chemokines, nano- and microdrug delivery, and future strategies to modulate macrophage functions in OA.

Suggestions

Du même auteur

Macrophages and joint inflammation: What's new in osteoarthritis?. Macrophages et inflammation articulaire : quoi de neuf dans l’arthrose ?

Archive ouverte | Gaigeard, Nicolas | CCSD

International audience. Osteoarthritis (OA) is an incurable, painful and debilitating joint disease that affects more than 500 million people worldwide. During OA, the synovial tissue is infiltrated by several cell ...

Osteoarthritic chondrocytes undergo a glycolysis-related metabolic switch upon exposure to IL-1b or TNF

Archive ouverte | Defois, Anais | CCSD

International audience. Background Osteoarthritis is an age-related disease that currently faces a lack of symptomatic treatment. Inflammation, which is mainly sustained by pro-inflammatory cytokines such as IL-1b, ...

Involvement of sphingosine kinase/sphingosine 1-phosphate metabolic pathway in spondyloarthritis

Archive ouverte | Bougault, Carole | CCSD

International audience. Spondyloarthritis (SpA) is a relatively common chronic inflammatory joint disorder, with a prevalence of about 0.2–0.5% worldwide. The primary target of the pathological process is the enthes...

Chargement des enrichissements...